Maxigen Biotech Inc.

1783

TW0001783009

Personal Products

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-06-03 EDT			5-day change	1st Jan Change
44.3 ^TWD	+3.99%		+5.60%	-8.47%

05-06	Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-03	Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2023 to December 31, 2023	CI

Maxigen Biotech Inc. Announces Resignation of Lu Min Hsuan as Chief Internal Auditor

May 13, 2022 at 06:57 am

Maxigen Biotech Inc. announced the resignation of Lu Min Hsuan as chief internal auditor of the company, with effect from May 13, 2022. The new chief internal auditor will be announced after audit committee and the board of directors approve the appointment.

Latest news about Maxigen Biotech Inc.

Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-05	CI
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2023 to December 31, 2023	05-03	CI
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Maxigen Biotech Inc.(TWSE:1783) added to S&P Global BMI Index	23-09-18	CI
Maxigen Biotech Inc. Declares Dividend, Payable on October 12, 2023	23-08-23	CI
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-26	CI
Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Maxigen Biotech Inc. Announces Cash Dividend for the Period from January 1, 2022 to December 31, 2022	23-05-03	CI
Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Maxigen Biotech Inc. Announces Executive Changes	23-03-22	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended December 2022	23-01-06	CI
Maxigen Biotech Inc. Announces Resignation of You Wan-How as Financial Officer and Accounting Officer	22-12-29	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended November 2022	22-12-06	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year to Date Ended October 2022	22-11-07	CI
Maxigen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-25	CI
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-To-Date Ended September 2022	22-10-05	CI
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year-to-Date Ended July 2022	22-08-09	CI
Maxigen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
Maxigen Biotech Inc. Reports Consolidated Revenues Results for the Month and Year-To-Date Ended June 2022	22-07-07	CI
Maxigen Biotech Inc. Announces Consolidated Revenue Results for the Month and Year to Date Ended May 2022	22-06-06	CI
Maxigen Biotech Inc. Announces Resignation of Lu Min Hsuan as Chief Internal Auditor	22-05-13	CI
Maxigen Biotech Inc. Reports Consolidated Revenue Results for the Month and Year to Date Ended April 2022	22-05-06	CI
Maxigen Biotech Inc. Approves the Appointment of You Wan-How, Manager as Financial Officer and Accounting Officer	22-05-03	CI
Maxigen Biotech Inc. Appoints Lin Yung-Hsiang to Nomination Committee	22-05-03	CI

Chart Maxigen Biotech Inc.

Duration

Period

More charts

Company Profile

MAXIGEN BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of biological products, the wholesale of all kinds of medical equipment, medicines, foods, masks, skin care products, as well as the manufacture and sales of chemical materials. The Company operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Sector

Personal Products

Calendar

2024-06-12 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
MAXIGEN BIOTECH INC.	-8.47%	117M
KAO CORPORATION	+19.86%	20.82B
GALDERMA GROUP AG	0.00%	19.12B
SHISEIDO COMPANY, LIMITED	+20.01%	12.79B
COTY INC.	-19.40%	8.81B
AMOREPACIFIC CORPORATION	+23.52%	8.38B
PROYA COSMETICS CO.,LTD.	+13.68%	6.02B
NATURA &CO HOLDING S.A.	-10.89%	3.96B
INTER PARFUMS, INC.	-16.17%	3.88B
KOSÉ CORPORATION	-0.71%	3.83B